Optical Coherence Tomography Classification Systems for Diabetic Macular Edema and Their Associations With Visual
Vivian W K Hui1,2, Simon K H Szeto1,2, Fangyao Tang1
1Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, china.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)
|December 19, 2021
Summary
Spectral-domain optical coherence tomography (SDOCT) classifications for diabetic macular edema (DME) are evolving. Current OCT parameters show prognostic value, but consensus is needed for reliable treatment outcome prediction.
Area of Science:
- Ophthalmology
- Medical Imaging
- Diabetology
Background:
- Diabetic macular edema (DME) is a leading cause of vision loss in diabetic patients.
- Optical coherence tomography (OCT) is crucial for DME detection and assessment.
- Existing OCT-based classification systems for DME require updates.
Purpose of the Study:
- To review recent spectral-domain OCT (SDOCT)-based DME classifications (past 5 years).
- To summarize OCT qualitative and quantitative parameters for disease severity, progression, and treatment outcomes.
- To discuss the need for a framework to validate biomarkers for DME treatment prognosis.
Main Methods:
- Review of recent literature on SDOCT-based DME classifications.
- Analysis of proposed OCT qualitative and quantitative parameters.
- Synthesis of data on prognostic value for visual outcomes and treatment response.
Main Results:
- Several OCT parameters (e.g., macular thickness, ellipsoid zone integrity) show prognostic value.
- Lack of consensus exists on reliable parameters for predicting treatment outcomes.
- A framework for biomarker validity is essential for DME prognosis.
Conclusions:
- SDOCT-based DME classifications are advancing, but standardization is lacking.
- Further research is needed to establish reliable OCT biomarkers for predicting treatment success in DME.
- Updating current diabetic retinal disease classifications is a recognized need.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
744
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
744
Glaucoma: Overview
954
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
954


